1. American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
   Lyndsay Harris et al, 2007, Journal of Clinical Oncology CrossRef
2. Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients
   Sze Chuen Cesar Wong et al, 2009, Clinical Cancer Research CrossRef
3. Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity
   Volkmar Müller et al, 2005, Clinical Cancer Research CrossRef
4. Therapeutic Strategies for Human Epidermal Receptor-2 Positive Metastatic Breast Cancer: A Literature Review
   FNU Sapna et al, 2020, Cureus CrossRef
5. HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer Patients
   Pia Wülfing et al, 2006, Clinical Cancer Research CrossRef
6. Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
   Massimo Cristofanilli et al, 2005, Journal of Clinical Oncology CrossRef
7. In Reply
   Katharina Pachmann, 2008, Journal of Clinical Oncology CrossRef
8. Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
   Harald Hugenschmidt et al, 2021, Cancers CrossRef